Unknown

Dataset Information

AXL kinase-mediated astrocytic phagocytosis modulates outcomes of traumatic brain injury.


ABSTRACT:

Background

Complex changes in the brain microenvironment following traumatic brain injury (TBI) can cause neurological impairments for which there are few efficacious therapeutic interventions. The reactivity of astrocytes is one of the keys to microenvironmental changes, such as neuroinflammation, but its role and the molecular mechanisms that underpin it remain unclear.

Methods

Male C57BL/6J mice were subjected to the controlled cortical impact (CCI) to develop a TBI model. The specific ligand of AXL receptor tyrosine kinase (AXL), recombinant mouse growth arrest-specific 6 (rmGas6) was intracerebroventricularly administered, and selective AXL antagonist R428 was intraperitoneally applied at 30 min post-modeling separately. Post-TBI assessments included neurobehavioral ass

SUBMITTER: Zhou H 

PROVIDER: S-EPMC8264993 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature